These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8970245)

  • 1. Preclinical evaluation of brimonidine.
    Burke J; Schwartz M
    Surv Ophthalmol; 1996 Nov; 41 Suppl 1():S9-18. PubMed ID: 8970245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenergic and imidazoline receptor-mediated responses to UK-14,304-18 (brimonidine) in rabbits and monkeys. A species difference.
    Burke J; Kharlamb A; Shan T; Runde E; Padillo E; Manlapaz C; Wheeler L
    Ann N Y Acad Sci; 1995 Jul; 763():78-95. PubMed ID: 7677389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of brimonidine on aqueous humor dynamics in human eyes.
    Toris CB; Gleason ML; Camras CB; Yablonski ME
    Arch Ophthalmol; 1995 Dec; 113(12):1514-7. PubMed ID: 7487618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brimonidine: a new alpha2-adrenoreceptor agonist for glaucoma treatment.
    Greenfield DS; Liebmann JM; Ritch R
    J Glaucoma; 1997 Aug; 6(4):250-8. PubMed ID: 9264305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the early effects of brimonidine and apraclonidine as topical ocular hypotensive agents.
    Maus TL; Nau C; Brubaker RF
    Arch Ophthalmol; 1999 May; 117(5):586-91. PubMed ID: 10326954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the short-term hypotensive effects and side effects of unilateral brimonidine and apraclonidine in patients with elevated intraocular pressure.
    Yüksel N; Karabaş L; Altintaş O; Yildirim Y; Cağlar Y
    Ophthalmologica; 2002; 216(1):45-9. PubMed ID: 11901288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brimonidine.
    Bakheit AH; Alomar AM; Darwish H; Alkahtani HM
    Profiles Drug Subst Excip Relat Methodol; 2023; 48():1-37. PubMed ID: 37061271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the efficacy of apraclonidine and brimonidine as aqueous suppressants in humans.
    Schadlu R; Maus TL; Nau CB; Brubaker RF
    Arch Ophthalmol; 1998 Nov; 116(11):1441-4. PubMed ID: 9823343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apraclonidine 0.5% versus brimonidine 0.2% for the control of intraocular pressure elevation following anterior segment laser procedures.
    Chevrier RL; Assalian A; Duperré J; Lesk MR
    Ophthalmic Surg Lasers; 1999 Mar; 30(3):199-204. PubMed ID: 10100253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular effects of a relatively selective alpha 2 agonist (UK-14, 304-18) in cats, rabbits and monkeys.
    Burke JA; Potter DE
    Curr Eye Res; 1986 Sep; 5(9):665-76. PubMed ID: 2876846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brimonidine 0.2% versus apraclonidine 0.5% for prevention of intraocular pressure elevations after anterior segment laser surgery.
    Chen TC; Ang RT; Grosskreutz CL; Pasquale LR; Fan JT
    Ophthalmology; 2001 Jun; 108(6):1033-8. PubMed ID: 11382625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brimonidine. A review of its pharmacological properties and clinical potential in the management of open-angle glaucoma and ocular hypertension.
    Adkins JC; Balfour JA
    Drugs Aging; 1998 Mar; 12(3):225-41. PubMed ID: 9534022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effect of alpha(2) agonist (brimonidine) on adult rat retinal ganglion cells after increased intraocular pressure.
    Ahmed FA; Hegazy K; Chaudhary P; Sharma SC
    Brain Res; 2001 Sep; 913(2):133-9. PubMed ID: 11549376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of systemic beta-blocker therapy on the efficacy and safety of topical brimonidine and timolol. Brimonidine Study Groups 1 and 2.
    Schuman JS
    Ophthalmology; 2000 Jun; 107(6):1171-7. PubMed ID: 10857839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing brimonidine 0.2% to apraclonidine 1.0% in the prevention of intraocular pressure elevation and their pupillary effects following laser peripheral iridotomy.
    Yuen NS; Cheung P; Hui SP
    Jpn J Ophthalmol; 2005; 49(2):89-92. PubMed ID: 15838723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aqueous humor flow in normal human eyes treated with brimonidine and timolol, alone and in combination.
    Larsson LI
    Arch Ophthalmol; 2001 Apr; 119(4):492-5. PubMed ID: 11296014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apraclonidine and brimonidine effects on anterior ocular and cardiovascular physiology in normal and sympathectomized monkeys.
    Gabelt BT; Robinson JC; Hubbard WC; Peterson CM; Debink N; Wadhwa A; Kaufman PL
    Exp Eye Res; 1994 Dec; 59(6):633-44. PubMed ID: 7698258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of brimonidine in children with glaucoma.
    Enyedi LB; Freedman SF
    J AAPOS; 2001 Oct; 5(5):281-4. PubMed ID: 11641636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute versus chronic effects of brimonidine on aqueous humor dynamics in ocular hypertensive patients.
    Toris CB; Camras CB; Yablonski ME
    Am J Ophthalmol; 1999 Jul; 128(1):8-14. PubMed ID: 10482088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of alpha-adrenoceptor agonists on human retinal microvessel diameter.
    Spada CS; Nieves AL; Burke JA; Wheeler LA; Woodward DF
    J Ocul Pharmacol Ther; 2001 Jun; 17(3):255-77. PubMed ID: 11436946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.